Eversept Partners’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-152,965
Closed -$948K 68
2024
Q2
$948K Buy
+152,965
New +$948K 0.06% 67